Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.10
Delayed Data
As of 4:00pm ET
 -0.15 / -6.67%
Today’s Change
1.78
Today|||52-Week Range
6.93
0.00%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close2.25
Today’s open2.35
Day’s range2.10 - 2.35
Volume250,113
Average volume (3 months)296,160
Market cap$68.9M
Dividend yield--
Data as of 4:00pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
CPHRCipher Pharmaceutica...-0.00-0.00%
CDNACareDx Inc-0.05-1.96%
ONCSOncoSec Medical Inc0.000.00%
TROVUTrovagene Inc0.000.00%
Data as of 3:59pm ET, 01/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Bill Welch
Vice President-Finance &
Administration
Elizabeth Anderson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs